Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter June 22, 2022

The predictive value of hemoglobin to creatinine ratio for contrast-induced nephropathy in percutaneous coronary interventions

  • Sencer Çamci , Mustafa Kinik , Selma Ari , Hasan Ari EMAIL logo , Mehmet Melek and Tahsin Bozat

Abstract

Objectives

Hemoglobin and creatinine levels are important factors for contrast induced nephropathy (CIN) development. Our aim in this study is to investigate the predictive value of hemoglobin to creatinine ratio for CIN development in patients with percutaneous coronary intervention (PCI).

Methods

A total of 500 patients who underwent PCI in our clinic were evaluated prospectively in terms of CIN. Hemoglobin to creatinine ratio is calculated as baseline hemoglobin/baseline serum creatinine value. glomerular filtration rate (GFR) was calculated with Cockcroft-Gault formula. The definition of CIN includes absolute (≥0.5 mg/dL) or relative increase (≥25%) in serum creatinine at 48–72 h after exposure to a contrast agent compared to baseline serum creatinine values.

Results

CIN was detected in 13.8% (69 patients) of 500 patients. In multivariate lineer regression analysis, hemoglobin to creatinine ratio (beta: −0.227, p=0.03) and ejection fraction (EF) (beta: −0.161, p<0.001), contrast amount used (beta: 0.231, p<0.001) were found to be significant predictors for the development of CIN. In receiver operating characteristics (ROC) analysis; AUC=0.730 (0.66–0.79) for hemoglobin to creatinine ratio, p<0.001, AUC=0.694 (0.62–0.76) for EF, p<0.001 and AUC=0.731 (0.67–0.78) for contrast amount used p<0.001.

Conclusions

Hemoglobin to creatinine ratio, EF and contrast amount used were independent predictors for CIN development in patients with PCI (NCT04703049).


Corresponding author: Dr. Hasan Ari, Professor, MD, Department of Cardiology, Bursa Yüksek İhtisas Eğitim ve Araştırma Hastanesi, Kardiyoloji Kliniği, Bursa, Turkey, Phone: 02243605050, Fax: 02243605055, E-mail:

  1. Research funding: None declared.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Informed consent was obtained from all individuals included in this study.

  5. Ethical approval: The approval of the hospital Ethics Committee (Bursa Postgraduate Hospital Ethics Committee) was obtained for the study.

References

1. Gandhi, S, Mosleh, W, Abdel-Qadir, H, Farkouh, ME. Statins and contrast-induced acute kidney injury with coronary angiography. Am J Med 2014;127:987–1000. https://doi.org/10.1016/j.amjmed.2014.05.011.Search in Google Scholar PubMed

2. Brar, SS, Shen, AY, Jorgensen, MB, Kotlewski, A, Aharonian, VJ, Desai, N, et al.. Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography: a randomized trial. JAMA 2008;300:1038–46. https://doi.org/10.1001/jama.300.9.1038.Search in Google Scholar PubMed

3. Rudnick, MR, Goldfarb, S, Wexler, L, Ludbrook, PA, Murphy, MJ, Halpern, EF, et al.. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. Kidney Int 1995;47:254–61. https://doi.org/10.1038/ki.1995.32.Search in Google Scholar PubMed

4. Palli, E, Makris, D, Papanikolaou, J, Garoufalis, G, Zakynthinos, E. Contrast-induced nephropathy in aged critically ill patients. Oxid Med Cell Longev 2014;2014:756469. https://doi.org/10.1155/2014/756469.Search in Google Scholar PubMed PubMed Central

5. Toprak, O, Cirit, M, Yesil, M, Bayata, S, Tanrisev, M, Varol, U, et al.. Impact of diabetic and pre-diabetic state on development of contrast-induced nephropathy in patients with chronic kidney disease. Nephrol Dial Transplant 2007;22:819–26. https://doi.org/10.1093/ndt/gfl636.Search in Google Scholar PubMed

6. Chong, E, Poh, KK, Liang, S, Tan, HC. Risk factors and clinical outcomes for contrast-induced nephropathy after percutaneous coronary intervention in patients with normal serum creatinine. Ann Acad Med Singapore 2010;39:374–80.10.47102/annals-acadmedsg.V39N5p374Search in Google Scholar

7. Mehran, R, Nikolsky, E. Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney Int Suppl 2006;69:S11–5. https://doi.org/10.1038/sj.ki.5000368.Search in Google Scholar PubMed

8. Xu, J, Zhang, M, Ni, Y, Shi, J, Gao, R, Wang, F, et al.. Impact of low hemoglobin on the development of contrast-induced nephropathy: a retrospective cohort study. Exp Ther Med 2016;12:603–10. https://doi.org/10.3892/etm.2016.3416.Search in Google Scholar PubMed PubMed Central

9. Pucelikova, T, Dangas, G, Mehran, R. Contrast-induced nephropathy. Cathet Cardiovasc Interv 2008;71:62–72. https://doi.org/10.1002/ccd.21207.Search in Google Scholar PubMed

10. Numasawa, Y, Ueda, I, Sawano, M, Kuno, T, Kodaira, M, Noma, S, et al.. Relation of baseline hemoglobin level to in-hospital outcomes in patients who undergo percutaneous coronary intervention (from a Japanese Multicenter Registry). Am J Cardiol 2018;121:695–702. https://doi.org/10.1016/j.amjcard.2017.12.007.Search in Google Scholar PubMed

11. Brener, SJ, Mehran, R, Dangas, GD, Ohman, EM, Witzenbichler, B, Zhang, Y, et al.. Relation of baseline hemoglobin levels and adverse events in patients with acute coronary syndromes (from the acute catheterization and urgent intervention triage strategy and harmonizing outcomes with revascularization and stents in acute myocardial infarction trials). Am J Cardiol 2017;119:1710–6. https://doi.org/10.1016/j.amjcard.2017.02.052.Search in Google Scholar PubMed

12. Fox, CS, Muntner, P, Chen, AY, Alexander, KP, Roe, MT, Cannon, CP, et al.. Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: a report from the national cardiovascular data acute coronary treatment and intervention outcomes network registry. Circulation 2010;121:357–65. https://doi.org/10.1161/circulationaha.109.865352.Search in Google Scholar

13. Parikh, PB, Jeremias, A, Naidu, SS, Brener, SJ, Lima, F, Shlofmitz, RA, et al.. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention. Cathet Cardiovasc Interv 2012;80:352–7. https://doi.org/10.1002/ccd.23394.Search in Google Scholar

14. Rao, SV, McCoy, LA, Spertus, JA, Krone, RJ, Singh, M, Fitzgerald, S, et al.. An updated bleeding model to predict the risk of post-procedure bleeding among patients undergoing percutaneous coronary intervention: a report using an expanded bleeding definition from the National Cardiovascular Data Registry CathPCI Registry. JACC Cardiovasc Interv 2013;6:897–904. https://doi.org/10.1016/j.jcin.2013.04.016.Search in Google Scholar

15. Brennan, JM, Curtis, JP, Dai, D, Fitzgerald, S, Khandelwal, AK, Spertus, JA, et al.. Enhanced mortality risk prediction with a focus on high-risk percutaneous coronary intervention: results from 1, 208, 137 procedures in the NCDR (National Cardiovascular Data Registry). JACC Cardiovasc Interv 2013;6:790–9. https://doi.org/10.1016/j.jcin.2013.03.020.Search in Google Scholar

16. Mehran, R, Aymong, ED, Nikolsky, E, Lasic, Z, Iakovou, I, Fahy, M, et al.. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 2004;44:1393–9. https://doi.org/10.1016/s0735-1097(04)01445-7.Search in Google Scholar

17. Pilgrim, T, Rothenbühler, M, Kalesan, B, Pulver, C, Stefanini, GG, Zanchin, T, et al.. Additive effect of anemia and renal impairment on long-term outcome after percutaneous coronary intervention. PLoS One 2014;9:e114846. https://doi.org/10.1371/journal.pone.0114846.Search in Google Scholar

18. Kitai, Y, Ozasa, N, Morimoto, T, Bao, B, Furukawa, Y, Nakagawa, Y, et al.. Prognostic implications of anemia with or without chronic kidney disease in patients undergoing elective percutaneous coronary intervention. Int J Cardiol 2013;168:5221–8. https://doi.org/10.1016/j.ijcard.2013.08.029.Search in Google Scholar

19. Giraldez, RR, Sabatine, MS, Morrow, DA, Mohanavelu, S, McCabe, CH, Antman, EM, et al.. Baseline hemoglobin concentration and creatinine clearance composite laboratory index improves risk stratification in ST-elevation myocardial infarction. Am Heart J 2009;157:517–24. https://doi.org/10.1016/j.ahj.2008.10.021.Search in Google Scholar

20. Mitchell, C, Rahko, PS, Blauwet, LA, Canaday, B, Finstuen, JA, Foster, MC, et al.. Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: recommendations from the American Society of Echocardiography. J Am Soc Echocardiogr 2019;32:1–64. https://doi.org/10.1016/j.echo.2018.06.004.Search in Google Scholar

21. Mehran, R, Owen, R, Chiarito, M, Baber, U, Sartori, S, Cao, D, et al.. A contemporary simple risk score for prediction of contrast-associated acute kidney injury after percutaneous coronary intervention: derivation and validation from an observational registry. Lancet 2021;398:1974–83. https://doi.org/10.1016/s0140-6736(21)02326-6.Search in Google Scholar

22. Nozue, T, Michishita, I, Iwaki, T, Mizuguchi, I, Miura, M. Contrast medium volume to estimated glomerular filtration rate ratio as a predictor of contrast-induced nephropathy developing after elective percutaneous coronary intervention. J Cardiol 2009;54:214–20. https://doi.org/10.1016/j.jjcc.2009.05.008.Search in Google Scholar

23. Maioli, M, Toso, A, Leoncini, M, Gallopin, M, Musilli, N, Bellandi, F. Persistent renal damage after contrast-induced acute kidney injury: incidence, evolution, risk factors, and prognosis. Circulation 2012;125:3099–107. https://doi.org/10.1161/circulationaha.111.085290.Search in Google Scholar

24. Maioli, M, Toso, A, Gallopin, M, Leoncini, M, Tedeschi, D, Micheletti, C, et al.. Preprocedural score for risk of contrast-induced nephropathy in elective coronary angiography and intervention. J Cardiovasc Med (Hagerstown). 2010;11:444–9. https://doi.org/10.2459/jcm.0b013e328335227c.Search in Google Scholar

25. Cigarroa, RG, Lange, RA, Williams, RH, Hillis, LD. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med 1989;86:649–52. https://doi.org/10.1016/0002-9343(89)90437-3.Search in Google Scholar

26. Fu, N, Li, X, Yang, S, Chen, Y, Li, Q, Jin, D, et al.. Risk score for the prediction of contrast-induced nephropathy in elderly patients undergoing percutaneous coronary intervention. Angiology 2013;64:188–94. https://doi.org/10.1177/0003319712467224.Search in Google Scholar PubMed

27. Chyrchel, M, Hałubiec, P, Łazarczyk, A, Duchnevič, O, Okarski, M, Gębska, M, et al.. Low ejection fraction predisposes to contrast-induced nephropathy after the second step of staged coronary revascularization for acute myocardial infarction: a retrospective observational study. J Clin Med 2020;9:1812. https://doi.org/10.3390/jcm9061812.Search in Google Scholar PubMed PubMed Central

28. Hsu, CY, McCulloch, CE, Curhan, GC. Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: results from the Third National Health and Nutrition Examination Survey. J Am Soc Nephrol 2002;13:504–10. https://doi.org/10.1681/asn.v132504.Search in Google Scholar PubMed

29. Waters, JS, O’Brien, ME, Ashley, S. Management of anemia in patients receiving chemotherapy. J Clin Oncol 2002;20:601–3. https://doi.org/10.1200/jco.2002.20.2.601.Search in Google Scholar

30. Kim, SJ, Salem, MR, Joseph, NJ, Madayag, MA, Cavallino, RP, Crystal, GJ. Contrast media adversely affect oxyhemoglobin dissociation. Anesth Analg 1990;71:73–6. https://doi.org/10.1213/00000539-199007000-00013.Search in Google Scholar PubMed

31. Nikolsky, E, Mehran, R, Lasic, Z, Mintz, GS, Lansky, AJ, Na, Y, et al.. Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions. Kidney Int 2005;67:706–13. https://doi.org/10.1111/j.1523-1755.2005.67131.x.Search in Google Scholar PubMed

32. Shah, AD, Nicholas, O, Timmis, AD, Feder, G, Abrams, KR, Chen, R, et al.. Threshold haemoglobin levels and the prognosis of stable coronary disease: two new cohorts and a systematic review and meta-analysis. PLoS Med 2011;8:e1000439. https://doi.org/10.1371/journal.pmed.1000439.Search in Google Scholar PubMed PubMed Central

33. Carson, JL, Noveck, H, Berlin, JA, Gould, SA. Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion. Transfusion 2002;42:812–8. https://doi.org/10.1046/j.1537-2995.2002.00123.x.Search in Google Scholar PubMed

34. Barbarova, I, Klempfner, R, Rapoport, A, Wasserstrum, Y, Goren, I, Kats, A, et al.. Avoidance of blood transfusion to patients suffering from myocardial injury and severe anemia is associated with increased long-term mortality: a retrospective cohort analysis. Medicine (Baltim) 2015;94:e1635. https://doi.org/10.1097/md.0000000000001635.Search in Google Scholar PubMed PubMed Central

35. Klein, MJ, Carter, TI, Smith, MC, Wong, J, Sugiyama, G. Prophylactic hypothermia and neuromuscular blockade to limit myocardial oxygen demand in a critically anemic Jehovah’s Witness after emergency surgery. J Surg Case Rep 2014;2014:rju135. https://doi.org/10.1093/jscr/rju135.Search in Google Scholar PubMed PubMed Central

36. Shimizu, A, Horikoshi, S, Rinnno, H, Kobata, M, Saito, K, Tomino, Y. Serum cystatin C may predict the early prognostic stages of patients with type 2 diabetic nephropathy. J Clin Lab Anal 2003;17:164–7. https://doi.org/10.1002/jcla.10087.Search in Google Scholar PubMed PubMed Central

37. Harjai, KJ, Raizada, A, Shenoy, C, Sattur, S, Orshaw, P, Yaeger, K, et al.. A comparison of contemporary definitions of contrast nephropathy in patients undergoing percutaneous coronary intervention and a proposal for a novel nephropathy grading system. Am J Cardiol 2008;101:812–9. https://doi.org/10.1016/j.amjcard.2007.10.051.Search in Google Scholar PubMed

38. Shemesh, O, Golbetz, H, Kriss, JP, Myers, BD. Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int 1985;28:830–8. https://doi.org/10.1038/ki.1985.205.Search in Google Scholar PubMed

39. Kwok, CS, Tiong, D, Pradhan, A, Andreou, AY, Nolan, J, Bertrand, OF, et al.. Meta-analysis of the prognostic impact of anemia in patients undergoing percutaneous coronary intervention. Am J Cardiol 2016;118:610–20. https://doi.org/10.1016/j.amjcard.2016.05.059.Search in Google Scholar PubMed

40. Numasawa, Y, Inohara, T, Ishii, H, Yamaji, K, Kohsaka, S, Sawano, M, et al.. Association of the hemoglobin to serum creatinine ratio with in-hospital adverse outcomes after percutaneous coronary intervention among non-dialysis patients: insights from a Japanese Nationwide Registry (J-PCI Registry). J Clin Med 2020;9:3612. https://doi.org/10.3390/jcm9113612.Search in Google Scholar PubMed PubMed Central

41. Shiraishi, J, Kohno, Y, Nakamura, T, Yanagiuchi, T, Hashimoto, S, Ito, D, et al.. Prognostic impact of chronic kidney disease and anemia at admission on in-hospital outcomes after primary percutaneous coronary intervention for acute myocardial infarction. Int Heart J 2014;55:301–6. https://doi.org/10.1536/ihj.13-367.Search in Google Scholar PubMed

Received: 2022-03-04
Accepted: 2022-06-03
Published Online: 2022-06-22
Published in Print: 2022-08-26

© 2022 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 4.3.2024 from https://www.degruyter.com/document/doi/10.1515/cclm-2022-0247/html
Scroll to top button